Outset Medical announced today that it received FDA 510(k) clearance for its next-generation Tablo hemodialysis platform.
Medical Device Network on MSN
Outset Medical secures FDA clearance for Tablo haemodialysis system
Outset Medical plans to begin shipping the updated platform during the second quarter of 2026.
The products and services mentioned below were selected independent of sales and advertising. However, Don't Waste Your Money may receive a small commission from the purchase of any products or ...
Investing.com -- Outset Medical Inc (NASDAQ:OM) stock jumped 9% in premarket trading Tuesday after the medical technology company announced FDA clearance for its next-generation Tablo dialysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results